Reuters UK | IFR-Sanofi CDS Tightens On Genzyme Deal Reuters LONDON, Feb 16 (IFR) - Sanofi-Aventis (SASY.PA) is one of the best performers on iTraxx Main this morning in percentage terms, tightening by around 5bp to 62bp, after finally acquiring US biotech company Genzyme (GENZ.O). The deal values Genzyme at ... BEFORE THE BELL: Futures Up After Genzyme Deal, Dell ResultsWall Street Journal Comte Says Sanofi Will Be Able to Retain Genzyme TalentBloomberg Banks, Sanofi-Aventis lead Europe higherMarketWatch Bizjournals.com -CNNMoney -TheStreet.com all 656 news articles |
Source: "Top Stories - Google News" via Glen in Google Reader
No comments:
Post a Comment